Abstract |
The effect of T-5224, a selective inhibitor of c-Fos/activator protein (AP)-1, on lipopolysaccharide (LPS) induced liver injury was examined in mice. Administration of LPS (10 mg kg(-1), i.p.) markedly increased serum levels of tumor necrosis factor-alpha (TNFα), high mobility group box 1 ( HMGB1), alanine aminotransferase/ aspartate aminotransferase (ALT/AST), liver tissue levels of macrophage-inflammatory protein-1 alpha (MIP-1α) and monocyte chemoattractant protein-1 (MCP-1), as well as hepatic necrosis and inflammation, leading to 67 % lethality. Administration of T-5224 (300 mg kg(-1), p.o.) after intraperitoneal injection of LPS imparted appreciable protection against acute elevations in serum levels of TNFα, HMGB1, ALT/AST as well as in liver tissue levels of MIP-1α and MCP-1, and reduced the lethality (27 %). These data indicate that T-5224 ameliorates liver injury and improves survival through decreasing production of proinflammatory cytokines and chemokines in endotoxemic mice.
|
Authors | Shinichiro Izuta, Masaaki Ueki, Masaki Ueno, Kahoru Nishina, Shunichi Shiozawa, Nobuhiro Maekawa |
Journal | Biotechnology letters
(Biotechnol Lett)
Vol. 34
Issue 12
Pg. 2175-82
(Dec 2012)
ISSN: 1573-6776 [Electronic] Netherlands |
PMID | 22927112
(Publication Type: Journal Article)
|
Chemical References |
- 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid
- Benzophenones
- Cytokines
- Enzymes
- Gastrointestinal Agents
- Isoxazoles
- Lipopolysaccharides
|
Topics |
- Animals
- Benzophenones
(administration & dosage, pharmacology)
- Chemical and Drug Induced Liver Injury
(prevention & control)
- Cytokines
(blood)
- Disease Models, Animal
- Enzymes
(blood)
- Gastrointestinal Agents
(administration & dosage, pharmacology)
- Hepatitis, Animal
(chemically induced, prevention & control)
- Isoxazoles
(administration & dosage, pharmacology)
- Lipopolysaccharides
(toxicity)
- Liver
(drug effects, pathology)
- Mice
- Survival Analysis
|